Choroidal Neovascularization (CNV) – Page 28 of 28
References L. Konstantinidis, I. Mantel, J-Antoine C. Pournaras et.a. Intravitreal ranibizumab (Lucentis) for the treatment of myopic choroidal neovascularization. Greafes Arch Clin Exp Ophthalmol 2009 247: 311-318 W-Mai Chan, Timothy Y, Y.Lai et al. Intravitreal Bevacizumab (Avastin) for Myopic Choroidal Neovascularization Six-Month Results of a Prospective Pilot Study. Ophthalmology 2007114:2190-2196 T.Yoshida, K. ohno-Matsui, K.